CoChat

Proinflammatory Stimulation and Pioglitazone Treatment Regulate Peroxisome Proliferator-Activated Receptor γ Levels in Peripheral Blood Mononuclear Cells from Healthy Controls and Multiple Sclerosis Patients

Klotz, Luisa, Schmidt, Martina, Giese, Thomas, Sastre, Magdalena, Knolle, Percy, Klockgether, Thomas, Heneka, Michael T · 2005 · The Journal of Immunology
Cited by 102

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

The peroxisome proliferator-activated receptor γ (PPAR-γ) belongs to a receptor superfamily of ligand-activated transcription factors involved in the regulation of metabolism and inflammation. Oral administration of PPAR-γ agonists ameliorates the clinical course and histopathological features in experimental autoimmune encephalomyelitis, an animal model for multiple sclerosis (MS), and PPAR-γ agonist treatment of PBMCs from MS patients suppresses PHA-induced cell proliferation and cytokine secretion. These effects are pronounced when cells are preincubated with the PPAR-γ agonists and reexposed at the time of stimulation, indicating a sensitizing effect. To characterize the mechanisms underlying this sensitizing effect, we analyzed PPAR-γ expression in PMBCs of MS patients and healthy controls. Surprisingly, MS patients exhibited decreased PPAR-γ levels compared with controls. PHA stimulation of PBMCs from healthy controls resulted in a significant loss of PPAR-γ, which was prevented by in vitro preincubation of the cells or in vivo by long-term oral medication with the PPAR-γ agonist pioglitazone. Differences in PPAR-γ expression were accompanied by changes in PPAR-γ DNA-binding activity, as preincubation with pioglitazone increased DNA binding of PPAR-γ. Additionally, preincubation decreased NF-κB DNA-binding activity to control levels, whereas the inhibitory protein IκBα was increased. In MS patients, pioglitazone-induced increase in PPAR-γ DNA-binding activity and decrease in NF-κB DNA-binding activity was only observed in the absence of an acute MS relapse. These results suggest that the sensitizing effect observed in the preincubation experiments is mediated by prevention of inflammation-induced suppression of PPAR-γ expression with consecutive increase in PPAR-γ DNA-binding activity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.175.8.4948

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 102

Metadata

Authors
Klotz, L., Schmidt, M., Giese, T., Sastre, M., Knolle, P., Klockgether, T., & Heneka, M. T.
Venue
The Journal of Immunology
Published
2005-10
Volume
175
Issue
8
Pages
4948-4955
ISSN
  • 0022-1767 (ISSN-L)
  • 1550-6606
OpenAlex
W1659730200
Cited by
102
References
4
FWCI
3.92
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.